Skip to content

Research at St Andrews

CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis

Research output: Contribution to journalArticle

Author(s)

Marty Richardson, Jamie Kirkham, Kerry Dwan, Derek J. Sloan, Geraint Davies, Andrea L. Jorgensen

School/Research organisations

Abstract

Background: Treatment with anti-tuberculosis drugs may cause patients to experience serious adverse effects. Genetic factors, such as polymorphisms of CYP genes, may increase the likelihood of a patient experiencing such adverse drug reactions. In this systematic review and meta-analysis, we synthesised evidence for associations between CYP genetic variants and anti-tuberculosis drug-related toxicity outcomes.

Methods: We searched MEDLINE, PubMed, EMBASE, BIOSIS and Web of Science to identify relevant studies. We performed meta-analyses to obtain an effect estimate for each genetic variant on each outcome, and stratified all analyses by country. We qualitatively assessed the methodological quality of the included studies.

Results: We included data from 28 distinct cohorts of patients in the review. We identified many areas of concern with regard to the quality of included studies. Patients with homozygous mutant-type or heterozygous genotype at the CYP2E1 RsaI polymorphism were significantly less likely to experience hepatotoxicity than patients with homozygous wild-type genotype (odds ratio [OR] = 0.75, 95% confidence interval [CI] 0.56–1.00; p = 0.047, I2 = 58.2%). No significant differences were observed for the CYP2E1 DraI and PstI polymorphisms. For the 96-bp deletion-insertion single-nucleotide polymorphism (SNP) of the CYP2E1 gene, homozygous mutant-type significantly increased hepatotoxicity risk compared with homozygous wild-type (OR = 8.20, 95% CI 1.38–48.68, I2 = 0%); no significant difference was observed for heterozygous genotype compared with homozygous wild-type (OR = 0.77, 95% CI 0.19–3.21, I2 = 0%).

Conclusions: Generally, we identified that coverage of the association between SNPs of CYP genes and anti-tuberculosis drug-related toxicity outcomes is incomplete. We observed significant associations between the RsaI and 96-bp deletion-insertion SNPs of the CYP2E1 gene and anti-tuberculosis drug-related hepatotoxicity. We were unable to comment on the impact of ethnicity on the investigated associations, as information on participants’ ethnicity was sparsely reported in the included studies.
Close

Details

Original languageEnglish
Article number204
Number of pages15
JournalSystematic Reviews
Volume7
DOIs
Publication statusPublished - 20 Nov 2018

    Research areas

  • Tuberculosis, Pharmacogenetics, Toxicity, Meta-analysis

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Genetic diversity of Mycobacterium tuberculosis clinical isolates in Blantyre, Malawi

    Ndhlovu, V., Kiran, A., Sloan, D., Mandala, W., Kontogianni, K., Kamdolozi, M., Caws, M. & Davies, G., Oct 2019, In : Heliyon. 5, 10, 5 p., e02638.

    Research output: Contribution to journalArticle

  2. A tuberculosis molecular bacterial load assay (TB-MBLA)

    Sabiiti, W., Mtafya, B. A., Alferes De Lima, D., Dombay, E., Baron, V. O., Azam, K., Orascova, K., Sloan, D. J. & Gillespie, S. H., 6 Sep 2019, (Accepted/In press) In : Journal of Visualized Experiments.

    Research output: Contribution to journalArticle

  3. Protocol for the development of the STrengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies

    Richardson, M., Kirkham, J. J., Dwan, K. M., Sloan, D. J., Davies, G. & Jorgensen, A., 11 Jul 2019, In : BMJ Open. 9, 7, 5 p., e030212.

    Research output: Contribution to journalArticle

  4. Linezolid for drug-resistant pulmonary tuberculosis

    Singh, B., Cocker, D., Ryan, H. & Sloan, D. J., 20 Mar 2019, In : Cochrane Database of Systematic Reviews. 2019, 3, CD012836.

    Research output: Contribution to journalReview article

  5. Evaluation of the efficacy of two methods for direct extraction of DNA from Mycobacterium tuberculosis sputum

    Ndhlovu, V., Mandala, W., Sloan, D., Kamdolozi, M., Caws, M. & Davies, G., 31 Dec 2018, In : Journal of Infection in Developing Countries. 12, 12, p. 1067-1072 6 p.

    Research output: Contribution to journalArticle

Related by journal

  1. Effect of the duration of antimicrobial exposure on the development of antimicrobial resistance (AMR) for macrolide antibiotics: protocol for a systematic review with a network meta-analysis

    Divala, T. H., Corbett, E. L., Stagg, H. R., Nliwasa, M., Sloan, D. J., French, N. & Fielding, K. L., 23 Dec 2018, In : Systematic Reviews. 7, 9 p., 246.

    Research output: Contribution to journalArticle

  2. Sensitivity and specificity of using trial-of-antibiotics versus sputum mycobacteriology for diagnosis of tuberculosis: protocol for a systematic literature review

    Divala, T. H., Fielding, K. L., Nliwasa, M., Sloan, D. J., Gupta-Wright, A. & Corbett, E. L., 15 Sep 2018, In : Systematic Reviews. 7, 5 p., 141.

    Research output: Contribution to journalReview article

  3. Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol)

    Richardson, M., Kirkham, J., Dwan, K., Sloan, D., Davies, G. & Jorgensen, A., 13 Jul 2017, In : Systematic Reviews. 6, 10 p., 142.

    Research output: Contribution to journalReview article

  4. Barriers and enablers to diabetic retinopathy screening attendance: protocol for a systematic review

    Graham-Rowe, E., Lorencatto, F., Lawrenson, J. G., Burr, J., Grimshaw, J. M., Ivers, N. M., Peto, T., Bunce, C., Francis, J. J. & WIDeR-EyeS Project team, 11 Aug 2016, In : Systematic Reviews. 5, 1, 9 p.

    Research output: Contribution to journalArticle

ID: 256653507

Top